Mark S. Chesnutt, M.D.

  • Professor of Medicine, Division of Pulmonary and Critical Care Medicine, School of Medicine
  • Director, Pacific Northwest Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, Dotter Interventional Institute, Interventional Radiology, School of Medicine

Education and training

    • M.D., 1986, Oregon Health & Science University

  • Internship

    • Internal Medicine, University of California, San Francisco. 1986-1987

  • Residency

    • Internal Medicine, University of California, San Francisco. 1987-1989
    • Chief Resident, Internal Medicine, University of California, San Francisco. 1989-1990

  • Fellowship

    • Pulmonary & Critical Care Medicine, University of California, San Francisco. 1992-1996

  • Certifications

    • Internal Medicine, 1989. Pulmonary Diseases, 1994, 2004, 2014. Critical Care Medicine, 1998, 2008

Areas of interest

  • HHT
  • Pulmonary arteriovenous fistula (PAVF)
  • Pulmonary arteriovenous malformation (PAVM)

Additional information

Publications

Elsevier pure profile

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}